drugset / Trial / NCT03627884

Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation

NCT03627884

Phase 4 Completed 451 enrolled Coney Island Hospital, Brooklyn, NY
RandomizedParallel-groupOpen-labelPrevention

Summary

Prospective, randomized, comparative clinical and open-label trial comparing sodium bicarbonate catheter lock solution (SBCLS) to normal saline catheter lock solution (NSCLS) use in HD patients with central venous catheters (CVC).

Timeline

Start
2016-10-01
Primary completion
2018-03-30
Completion
2018-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium bicarbonate Diagnostic / imaging agent 7.5 % Other
Comparator sodium bicarbonate Diagnostic / imaging agent 8.4 % Other
Comparator sodium chloride Unknown 0.9 % Other